SLC11A2 and Tangier disease: Studies have shown that hepcidin decreases dietary iron absorption by inhibiting iron transport in enterocytes through downregulation of DMT1 and suppression of ferroportin activity (53–55), whereas in hepatocytes it prevents the mobilization of hepatic iron stores resulting in iron overload (52).